CV Lattes
ORCID
Google Scholar Citations
Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE). Hospital Israelita Albert Einstein (Institutional affiliation from the last research proposal) Birthplace: Brazil
PhD in Genetics and Molecular Biology from the University of Campinas (UNICAMP), with a research project conducted at the National Center for Research in Energy and Materials (CNPEM) and the Butantan Institute, focused on drug screening using phenotypic assays (High Content Screening). Has experience in bioinformatics applied to medical genomics, including a lato sensu specialization from the Faculdade Israelita Albert Einstein (2021-2022), as well as experience as a developer at the genetic diagnostics company Mendelics (2022-2024). In 2025, developed the web tool VariaACT (https://variact.app/). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Leishmaniasis is a set of clinical manifestations caused by protozoa of the genus Leishmania. With an estimated 12 million people infected, it is a public health problem, being considered one of the ten priority global epidemics. However, it has not an effective treatment, safe, easily manageable and economically viable. All drugs in use or advanced clinical stage have limitations such as…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships in Brazil |
| 2 / 2 | All Scholarships |
| Associated processes | |